NICE guidance on pirfenidone for treating idiopathic pulmonary fibrosis

被引：15

作者：

Landells, Linda J. ^{[1
]}

Naidoo, Bhash ^{[1
]}

Robertson, Janet ^{[1
]}

Clark, Peter ^{[1
]}

机构：

[1] Natl Inst Hlth & Care Excellence, London, England

来源：

LANCET RESPIRATORY MEDICINE | 2013年 / 1卷 / 03期

关键词：

D O I：

10.1016/S2213-2600(13)70065-1

中图分类号：

R4 [临床医学];

学科分类号：

100218 [急诊医学];

摘要：

引用

页码：191 / 192

页数：2

共 6 条

[1]

Cooper K, 2012, PIRFENIDONE TREATMEN

[2]

NICE, 2011, PIRF TREATM ID PULM

[3]

NICE, 2012, ID PULM FIBR PIRF AP

[4]

NICE, 2013, TECHN APPR GUID TA28

[5]

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials [J].

Noble, Paul W. ;

Albera, Carlo ;

Bradford, Williamson Z. ;

Costabel, Ulrich ;

Glassberg, Marilyn K. ;

Kardatzke, David ;

King, Talmadge E., Jr. ;

Lancaster, Lisa ;

Sahn, Steven A. ;

Szwarcberg, Javier ;

Valeyre, Dominique ;

du Bois, Roland M. .

LANCET, 2011, 377 (9779) :1760-1769

[6]

Prednisone, Azathioprine, and N-Acetylcysteine for Pulmonary Fibrosis [J].

Raghu, Ganesh ;

Anstrom, Kevin J. ;

King, Talmadge E., Jr. ;

Lasky, Joseph A. ;

Martinez, Fernando J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (21) :1968-1977

← 1 →